Skip to main content
main-content

Connective tissue diseases

Comorbidities

Immunogenicity of influenza vaccine confirmed in patients with rheumatic disease

Influenza vaccination gives rise to an adequate immune response among patients with rheumatic conditions, researchers report.

25-02-2019 | Vaccination | Highlight | News

Immunogenicity of influenza vaccine confirmed in patients with rheumatic disease

Influenza vaccination gives rise to an adequate immune response among patients with rheumatic conditions, researchers report.

Emerging therapies for lupus nephritis

Lupus nephritis is the most common organ-threatening complication of systemic lupus erythematosus, and current treatment regimens are only partially effective and are potentially toxic. In this editorial, the authors focus on emerging therapeutics to treat this disease.

29-01-2019 | Lupus nephritis | Editorial | Article

Emerging therapies for lupus nephritis

Lupus nephritis is the most common organ-threatening complication of systemic lupus erythematosus, and current treatment regimens are only partially effective and are potentially toxic. In this editorial, the authors focus on emerging therapeutics to treat this disease.

17-12-2018 | Systemic lupus erythematosus | News

Lupus tied to increased cancer risk

Findings from a meta-analysis indicate that systemic lupus erythematosus is associated with an increased risk for 16 types of cancer.

04-12-2018 | Comorbidities | Article

Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study

Panopoulos S et al. Arthritis Res Ther 2018. doi: 10.1186/s13075-018-1771-0

24-10-2018 | Pediatric | ACR/ARHP 2018 | Video

Expert highlights: Sangeeta Sule

Editorial board member Sangeeta Sule discusses her highlights from the pediatric rheumatology sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA (2:14).

Vaccination in children and adolescents with rheumatic conditions

In this editorial, the authors discuss the risks of live vaccination in children taking antirheumatic medications and how to manage these, as well as how health authorities can address decreasing vaccination coverage of the general public.

18-10-2018 | Infection | Editorial | Article

Vaccination in children and adolescents with rheumatic conditions

In this editorial, the authors discuss the risks of live vaccination in children taking antirheumatic medications and how to manage these, as well as how health authorities can address decreasing vaccination coverage of the general public.

Planning and managing pregnancy in lupus patients

Megan Clowse discusses the importance of planning pregnancy in patients with lupus to avoid high-risk pregnancy, and outlines strategies to manage active lupus during pregnancy.

16-10-2018 | Pregnancy | Editorial | Article

Planning and managing pregnancy in lupus patients

Megan Clowse discusses the importance of planning pregnancy in patients with lupus to avoid high-risk pregnancy, and outlines strategies to manage active lupus during pregnancy.

01-10-2018 | Systemic sclerosis | Article

Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis

Tennøe AH et al. J Am Coll Cardiol 2018; 72: 1804–1813. doi: 10.1016/j.jacc.2018.07.068

26-09-2018 | Systemic lupus erythematosus | News

Depression linked to increased SLE risk

Women with a history of depression are more than twice as likely as those without depression to develop systemic lupus erythematosus, shows an analysis of data from the Nurses’ Health Study.

Rheumatic immune-related adverse events from cancer immunotherapy

In this review, mechanisms of action of checkpoint inhibitors and how they might cause rheumatic immune-related adverse events are described [read more].
Calabrese LH, Calabrese C, Cappelli LC. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0074-9

12-09-2018 | Sjögren’s syndrome | News

Primary Sjögren’s syndrome linked to subclinical CVD

Patients with primary Sjögren’s syndrome may have an elevated risk for subclinical cardiovascular disease, researchers report.

31-08-2018 | Immune checkpoint inhibitor-induced rheumatic disease | Review | Article

Rheumatic immune-related adverse events from cancer immunotherapy

Calabrese LH, Calabrese C, Cappelli LC. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0074-9

23-08-2018 | Systemic lupus erythematosus | News

Noninvasive method could detect subclinical cardiac impairment in SLE patients

Cardiac magnetic resonance imaging could be used to identify subclinical cardiac impairment in patients with systemic lupus erythematosus, researchers report.

image credits